Citation Impact
Citing Papers
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia
2016 StandoutNobel
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
2012
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Amelioration of graft versus host disease by galectin-1
2003
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
2010
Nephrotic Syndrome after Hematopoietic Cell Transplantation
2006
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
2005
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
TFOS DEWS II pathophysiology report
2017 Standout
Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease
2006
Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation
2005
Chronic graft-versus-host disease
2003 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Peripheral blood stem cell mobilization: The CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties
2006
Graft-versus-host disease
2009 Standout
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
2004
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sirolimus and Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation
2005
The management and outcome of chronic graft‐versus‐host disease
2007
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease: Does It Work?
2006
Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia
2015
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Immunity to fungal infections
2011 Standout
Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment
2004
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
2002
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
2005
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
2001
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study
2003
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells
2003
Works of N Basara being referenced
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study
2001
Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab
2001
Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant
2000
New therapeutic modalities in the treatment of graft-versus-host disease
2001
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA‐mismatched bone marrow transplant patients
2000
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation
2000
Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT
2001
New strategies in the treatment of graft-versus-host disease
2000